Eco Animal Regulatory News (EAH)

ECO Animal Health Group plc

(''ECO" or "the ECO Group") (AIM: EAH)

Investor Presentation

ECO Animal Health Group plc (AIM: EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that Marc Loomes, CEO, Christopher Wilks, CFO, and Hafid Benchaoui, Global Head of R&D, will be conducting a live presentation following their Capital Markets Day to institutional investors at 9am.

The online presentation will take place on Wednesday 26th January at 2.30pm London time.

ECO started a programme of significant R&D investment in vaccines around four years ago and has seen meaningful progress. This event will be an opportunity for investors to hear insights from the management team and further details of the potential commercial value that exists within the new product development pipeline.

The presentation is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end.

To register for the online event, please go to: https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-investorspresentation-26jan

A recording of the presentation will be available shortly after the event.

Contacts:

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.